GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Glow LifeTech Corp (XCNQ:GLOW) » Definitions » FCF Margin %

Glow LifeTech (XCNQ:GLOW) FCF Margin % : -421.05% (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Glow LifeTech FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Glow LifeTech's Free Cash Flow for the three months ended in Sep. 2023 was C$-0.08 Mil. Glow LifeTech's Revenue for the three months ended in Sep. 2023 was C$0.02 Mil. Therefore, Glow LifeTech's FCF Margin % for the quarter that ended in Sep. 2023 was -421.05%.

As of today, Glow LifeTech's current FCF Yield % is -30.51%.

The historical rank and industry rank for Glow LifeTech's FCF Margin % or its related term are showing as below:

XCNQ:GLOW' s FCF Margin % Range Over the Past 10 Years
Min: -3926.32   Med: 0   Max: 0
Current: -3926.32


XCNQ:GLOW's FCF Margin % is ranked worse than
86.04% of 1046 companies
in the Biotechnology industry
Industry Median: -144.01 vs XCNQ:GLOW: -3926.32


Glow LifeTech FCF Margin % Historical Data

The historical data trend for Glow LifeTech's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glow LifeTech FCF Margin % Chart

Glow LifeTech Annual Data
Trend Dec19 Dec20 Dec21 Dec22
FCF Margin %
- - - -

Glow LifeTech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -421.05

Competitive Comparison of Glow LifeTech's FCF Margin %

For the Biotechnology subindustry, Glow LifeTech's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Glow LifeTech's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Glow LifeTech's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Glow LifeTech's FCF Margin % falls into.



Glow LifeTech FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Glow LifeTech's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-1.357/0
= %

Glow LifeTech's FCF Margin for the quarter that ended in Sep. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-0.08/0.019
=-421.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Glow LifeTech FCF Margin % Related Terms

Thank you for viewing the detailed overview of Glow LifeTech's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Glow LifeTech (XCNQ:GLOW) Business Description

Traded in Other Exchanges
Address
65 International Boulevard, Suite 206, Etobicoke, ON, CAN, M9W 6L9
Glow LifeTech Corp is a biotechnology company focused on producing nutraceutical and cannabinoid-based products with dramatically enhanced bioavailability, absorption, and effectiveness. Its plant-based MyCell Technology delivery system transforms poorly absorbed natural compounds into enhanced water-compatible concentrates, unlocking the full healing potential of natural active compounds.
Executives
Daniel Proska Director

Glow LifeTech (XCNQ:GLOW) Headlines

No Headlines